Nanoparticle Labeling of Bone Marrow-Derived Rat Mesenchymal Stem Cells: Their Use in Differentiation and Tracking

<div>Characterization and labelling efficiency of 24 h CPN treated and nontreated MSCs. (a) After CPN-labeling MSCs (left panel) were positive for mesenchymal stem cell markers (CD90, CD29, and CD71) and negative for hematopoietic stem cell markers (CD34 and CD45) same as nontreated MSCs (right panel). <i>β</i>-Actin was used for loading control. (b) CPN-MSCs were visualized by fluorescence microscopy by using FITC filters. DAPI staining was performed to visualize cellular DNA. Magnification bar: 100 <i>μ</i>m.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Nanoparticle Labeling of Bone Marrow-Derived Rat Mesenchymal Stem Cells: Their Use in Differentiation and Tracking 